SEC Form 4 · accession 0001209191-16-137737
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean F. Moran
Officer — Chief Financial Officer
Period of report
Aug 17, 2016
Accepted (ET)
Aug 18, 2016 · 1:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2016 | P | 83,960 | $3.19 | A | 216,410 | D | |
| Common Stock | Aug 18, 2016 | P | 65,000 | $3.48 | A | 281,410 | D |
Table II — derivative securities
No Table II lines on this filing.